Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ASP1517 with Kremezin in Healthy Men
NCT02693613Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of roxadustat in anemia (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity and Maximum Plasma Concentration. Started Feb 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02693613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693613.